Literature DB >> 18936713

Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004.

Amnon Sonnenberg1.   

Abstract

AIM: The aim of the study was to use hospitalization data for the analysis of inflammatory bowel disease time trends in the United States.
METHODS: US hospital utilization data were available for individual years from 1970 to 2004 through the National Hospital Discharge Survey. Age-specific rates of hospitalization were calculated for consecutive 5-year periods.
RESULTS: An increase in the rates of hospitalization for Crohn's disease was most pronounced in the age group 65+ followed by the age group 45 to 64. By contradistinction, the rates in the youngest age group 0 to 44 stayed largely unchanged. In ulcerative colitis, a significant increase in hospitalization rates was limited to the oldest age group, whereas the rates in the middle and young age group remained unchanged.
CONCLUSIONS: Extrapolation of the current trends suggests that in the future the hospitalization for inflammatory bowel disease may start to level off. This may occur earlier and be more pronounced in younger age groups and patients with ulcerative colitis than Crohn's disease.

Entities:  

Mesh:

Year:  2009        PMID: 18936713     DOI: 10.1097/MCG.0b013e31816244a0

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States.

Authors:  Anne F Peery; Seth D Crockett; Alfred S Barritt; Evan S Dellon; Swathi Eluri; Lisa M Gangarosa; Elizabeth T Jensen; Jennifer L Lund; Sarina Pasricha; Thomas Runge; Monica Schmidt; Nicholas J Shaheen; Robert S Sandler
Journal:  Gastroenterology       Date:  2015-08-29       Impact factor: 22.682

Review 2.  Quality of care delivered to hospitalized inflammatory bowel disease patients.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 3.  Natural history and complications of IBD.

Authors:  Morten H Vatn
Journal:  Curr Gastroenterol Rep       Date:  2009-12

4.  Demographic characteristics of hospitalized IBD patients.

Authors:  Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

5.  Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis.

Authors:  Sunil Samuel; Steven B Ingle; Shamina Dhillon; Siddhant Yadav; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; William J Sandborn; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

Review 6.  Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

Authors:  Petra A Golovics; Michael D Mandel; Barbara D Lovasz; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

7.  Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017).

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar; Joel J Toledo-Mauriño; Katya E Bozada-Gutiérrez; Francisco J Bosques-Padilla; Manuel A Martínez-Vázquez; Virgilio Marroquín-Jiménez; Rosalva García-Figueroa; Christian Jaramillo-Buendía; Rosa M Miranda-Cordero; Jesús A Valenzuela-Pérez; Yolanda Cortes-Aguilar; Janett S Jacobo-Karam; Emilio F Bermudez-Villegas
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease.

Authors:  Marrieth G Rubio; Kofi Amo-Mensah; James M Gray; Vu Q Nguyen; Sam Nakat; Douglas Grider; Kim Love; James H Boone; Dario Sorrentino
Journal:  World J Gastrointest Pathophysiol       Date:  2019-12-31

9.  Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis.

Authors:  Flávia Gonçalves Musauer Palacio; Lucila Marieta Perrotta de Souza; Jéssica Pronestino de Lima Moreira; Ronir Raggio Luiz; Heitor Siffert Pereira de Souza; Cyrla Zaltman
Journal:  BMC Gastroenterol       Date:  2021-04-27       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.